Sign in to view content

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD

Michael N. Cohen, MD

Video
Published 2020

Related

Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019
It’s the Patient, Not the Agent: An Assessment of Anti-VEGF Extended Dosing Intervals in Patients With nAMD
David A. Eichenbaum, MD, FASRS
On Demand Cases, Courses, and Papers
2019
Wet AMD
Jared Watson
Paul Yates, MD, PhD
Retina Image Bank: Images of the Week
2015

Category: Age-Related Macular Degeneration

See more